Triheptanoin Patent Expiration

Triheptanoin was first introduced by Ultragenyx Pharmaceutical Inc in its drug Dojolvi on Jun 30, 2020.


Triheptanoin Patents

Given below is the list of patents protecting Triheptanoin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Dojolvi US8697748 Glycogen or polysaccharide storage disease treatment method Apr 28, 2029 Ultragenyx Pharm Inc
Dojolvi US9186344 Glycogen or polysaccharide storage disease treatment method Jul 01, 2025 Ultragenyx Pharm Inc



Triheptanoin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List